Skip to Main Content

Paper Details

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
0
2023
Author NameAffiliation
Eugene BraunwaldBrigham and Women's Hospital
Eugene BraunwaldHarvard Medical School
  • 1 - 2

Datasets

Release 1.2